Natera Total Liabilities 2014-2025 | NTRA
Natera total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Natera total liabilities for the quarter ending June 30, 2025 were $0.511B, a 24.92% decline year-over-year.
- Natera total liabilities for 2024 were $0.465B, a 31.2% decline from 2023.
- Natera total liabilities for 2023 were $0.676B, a 1.79% decline from 2022.
- Natera total liabilities for 2022 were $0.689B, a 18.1% increase from 2021.
| Natera Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $465 |
| 2023 | $676 |
| 2022 | $689 |
| 2021 | $583 |
| 2020 | $446 |
| 2019 | $304 |
| 2018 | $236 |
| 2017 | $189 |
| 2016 | $104 |
| 2015 | $80 |
| 2014 | $54 |
| 2013 | $46 |
| Natera Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-06-30 | $511 |
| 2025-03-31 | $493 |
| 2024-12-31 | $465 |
| 2024-09-30 | $712 |
| 2024-06-30 | $680 |
| 2024-03-31 | $674 |
| 2023-12-31 | $676 |
| 2023-09-30 | $662 |
| 2023-06-30 | $652 |
| 2023-03-31 | $668 |
| 2022-12-31 | $689 |
| 2022-09-30 | $647 |
| 2022-06-30 | $622 |
| 2022-03-31 | $602 |
| 2021-12-31 | $583 |
| 2021-09-30 | $552 |
| 2021-06-30 | $551 |
| 2021-03-31 | $521 |
| 2020-12-31 | $446 |
| 2020-09-30 | $441 |
| 2020-06-30 | $419 |
| 2020-03-31 | $300 |
| 2019-12-31 | $304 |
| 2019-09-30 | $296 |
| 2019-06-30 | $290 |
| 2019-03-31 | $256 |
| 2018-12-31 | $236 |
| 2018-09-30 | $221 |
| 2018-06-30 | $216 |
| 2018-03-31 | $223 |
| 2017-12-31 | $189 |
| 2017-09-30 | $174 |
| 2017-06-30 | $108 |
| 2017-03-31 | $102 |
| 2016-12-31 | $104 |
| 2016-09-30 | $102 |
| 2016-06-30 | $97 |
| 2016-03-31 | $84 |
| 2015-12-31 | $80 |
| 2015-09-30 | $56 |
| 2015-06-30 | $64 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2013-12-31 | $46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.227B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.003B | 27.08 |
| CVS Health (CVS) | United States | $90.597B | 11.27 |
| Elevance Health (ELV) | United States | $69.715B | 9.38 |
| Cencora (COR) | United States | $58.790B | 19.58 |
| DiDi Global (DIDIY) | China | $29.369B | 31.20 |
| Labcorp Holdings (LH) | United States | $22.982B | 18.27 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.490B | 0.00 |
| ICON (ICLR) | Ireland | $14.189B | 13.65 |
| Medpace Holdings (MEDP) | United States | $12.736B | 33.71 |
| CochLear (CHEOY) | Australia | $12.699B | 0.00 |
| Solventum (SOLV) | United States | $12.484B | 12.88 |
| Viatris (VTRS) | United States | $12.463B | 4.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.720B | 0.00 |
| Revvity (RVTY) | United States | $10.408B | 18.34 |
| Avantor (AVTR) | United States | $8.563B | 12.56 |
| Sonic Healthcare (SKHHY) | Australia | $7.992B | 0.00 |
| HealthEquity (HQY) | United States | $7.874B | 34.49 |
| Charles River Laboratories (CRL) | United States | $7.606B | 14.43 |
| Bausch + Lomb (BLCO) | Canada | $5.133B | 34.52 |
| Sotera Health (SHC) | United States | $4.525B | 25.29 |
| BrightSpring Health Services (BTSG) | United States | $4.244B | 32.38 |
| KindlyMD (NAKA) | United States | $3.998B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.468B | 79.42 |
| Alignment Healthcare (ALHC) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.949B | 18.71 |
| Surgery Partners (SGRY) | United States | $2.931B | 36.87 |
| Organon (OGN) | United States | $2.412B | 2.63 |
| Premier (PINC) | United States | $2.106B | 19.53 |
| Progyny (PGNY) | United States | $1.989B | 42.06 |
| Ardent Health (ARDT) | United States | $1.826B | 7.05 |
| PACS (PACS) | United States | $1.788B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.560B | 26.41 |
| Pediatrix Medical (MD) | United States | $1.406B | 9.39 |
| Teladoc Health (TDOC) | United States | $1.270B | 0.00 |
| Omada Health (OMDA) | $1.236B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.159B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.809B | 4.74 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 9.31 |
| CareDx (CDNA) | United States | $0.666B | 12.27 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| Nutex Health (NUTX) | United States | $0.534B | 8.09 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 6.98 |
| SBC Medicals (SBC) | United States | $0.438B | 9.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 26.63 |
| So-Young (SY) | China | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| LifeMD (LFMD) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.186B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |